Nov 22, 2016
1:14
For every 14 shares held, investors received 1. The price per share adjusted from $0.60 to $0.04.
The split itself did not change the total investment value.
KalVista Pharmaceuticals, Inc. (KALV) trades on the NASDAQ in the Biotechnology industry.
KalVista Pharmaceuticals, Inc. company overviewThe latest split shown was on November 22, 2016. It was a 1-for-14 reverse split, so shareholders received 1 share for every 14 they held.
This history records one reverse split, on November 22, 2016.